pharmaceutical investing Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
pharmaceutical investing Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix
Prismo Metals Reports 4,811 g/t Silver and Confirms Deep Porphyry Copper Potential Beneath Historic Silver King Mine, near Resolution Copper in Arizona
Steadright Removes Titanbeach One Technical Report And Retains Qualified Geologist For New Technical Report
